Market Overview

Technical Alert: Valeant Pharmaceuticals Surrenders Early Gains After Asset Sale

Share:
Related VRX
Valeant Surrenders Early Gains After SILIQ's FDA Approval
Wall Street Buys Valeant After Ackman Cuts Stake
PRO Weekly Digest: The Art Of Short Selling With Ioannis Tsoutsias, CFA (Seeking Alpha)
  • $17.65 - November 28 high
  • $17.59 - November 29 high
  • $17.55 - Current high as of 10:04 AM
  • $16.70 - Current price as of 10:04 AM
  • $16.64 - Current low as of 10:04 AM
  • $15.35 - Monday close

Posted-In: Technicals Intraday Update Movers Trading Ideas

 

Related Articles (VRX)

View Comments and Join the Discussion!